Agenus Inc (AGEN):企業の財務・戦略的SWOT分析

◆英語タイトル:Agenus Inc (AGEN) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1337
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,125見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,375見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Agenus Inc (AGEN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Agenus Inc (Agenus) is a clinical-stage immuno-oncology company that discovers, develops and commercializes a wide range of immunotherapeutics for the treatment of various types of cancers and infectious diseases. The company’s pipeline portfolio encompasses vaccines for glioblastoma, genital herpes, and multiple cancer types; vaccine adjuvants for the treatment of shingles and malaria; and checkpoint antibodies targeted at various diseases. The company’s technology portfolio includes antibody discovery platform, vaccine platforms and Heat Shock Protein (HSP) platform. The company has collaborations with several pharmaceutical companies such as GSK, Incyte, and Merck. It operates in the US and Europe. Agenus is headquartered in Lexington, Massachusetts, the US.

Agenus Inc Key Recent Developments

Mar 12,2020: Agenus reports fourth quarter and full year 2019 financial results and provides corporate update
Jan 09,2020: Agenus announces the appointment of Dr. Jennifer Buell to the position of President and COO
Nov 04,2019: Agenus provides corporate update with third quarter 2019 financial results
Aug 08,2019: Agenus reports second quarter 2019 financial results and provides corporate update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Agenus Inc – Key Facts
Agenus Inc – Key Employees
Agenus Inc – Key Employee Biographies
Agenus Inc – Major Products and Services
Agenus Inc – History
Agenus Inc – Company Statement
Agenus Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Agenus Inc – Business Description
Geographical Segment: Europe
Performance
Geographical Segment: United States
Performance
Agenus Inc – Corporate Strategy
Agenus Inc – SWOT Analysis
SWOT Analysis – Overview
Agenus Inc – Strengths
Agenus Inc – Weaknesses
Agenus Inc – Opportunities
Agenus Inc – Threats
Agenus Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Agenus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Agenus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Agenus Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 12, 2020: Agenus reports fourth quarter and full year 2019 financial results and provides corporate update
Jan 09, 2020: Agenus announces the appointment of Dr. Jennifer Buell to the position of President and COO
Nov 04, 2019: Agenus provides corporate update with third quarter 2019 financial results
Aug 08, 2019: Agenus reports second quarter 2019 financial results and provides corporate update
Jul 18, 2019: Agenus appoints Don Vidic as Vice President and Head of Commercial
May 09, 2019: Agenus reports first quarter 2019 financial results and provides corporate update
Mar 21, 2019: Agenus announces clinical appointments
Mar 14, 2019: Agenus reports fourth quarter and full year 2018 financial results and provides corporate update
Feb 19, 2019: Agenus Launches First Asset-Backed Digital-Security Offering in Healthcare
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Agenus Inc, Key Facts
Agenus Inc, Key Employees
Agenus Inc, Key Employee Biographies
Agenus Inc, Major Products and Services
Agenus Inc, History
Agenus Inc, Subsidiaries
Agenus Inc, Key Competitors
Agenus Inc, Ratios based on current share price
Agenus Inc, Annual Ratios
Agenus Inc, Annual Ratios (Cont...1)
Agenus Inc, Interim Ratios
Agenus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Agenus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Agenus Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Agenus Inc, Performance Chart (2015 - 2019)
Agenus Inc, Ratio Charts
Agenus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Agenus Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Agenus Inc (AGEN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Enerjisa Enerji Uretim AS:企業の戦略的SWOT分析
    Enerjisa Enerji Uretim AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • French National Institute of Health and Medical Research:医療機器:M&Aディール及び事業提携情報
    Summary French National Institute of Health and Medical Research (INSERM) is a biomedical research institute that conducts research in biology, medicine and public health. The institute offers research in the therapeutic areas of neurosciences, cognitive sciences, neurology, psychiatry, cancer, immu …
  • Rowan Companies Plc (RDC):石油・ガス:M&Aディール及び事業提携情報
    Summary Rowan Companies Plc (Rowan) is a provider of offshore contract drilling services to the oil and gas industry. It provides drilling services in the in the ultra-deepwater and shallow water jack-up market. Rowan operates self-elevating mobile offshore drilling units and ultra-deepwater drillsh …
  • NanoPass Technologies Ltd:医療機器:M&Aディール及び事業提携情報
    Summary NanoPass Technologies Ltd (NanoPass) is a medical device company that develops and commercializes intradermal delivery solutions for vaccines and drugs. The company's product include MicronJet600 needle, a single use microneedles based device for intradermal delivery. Its micronjet microneed …
  • Shaw Communications Inc (SJR.B):企業の財務・戦略的SWOT分析
    Shaw Communications Inc (SJR.B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Ameriprise Financial, Inc.:企業の戦略・SWOT・財務分析
    Ameriprise Financial, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ameriprise Financial, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Otello Corp ASA (OTELLO):企業の財務・戦略的SWOT分析
    Otello Corp ASA (OTELLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Halliburton Co (HAL)-石油・ガス分野:企業M&A・提携分析
    Summary Halliburton Company (Halliburton) is an oilfield services company. The company serves the upstream oil and gas industry throughout the lifecycle of the reservoir, from identifying hydrocarbons and managing geological data, to drilling and formation evaluation, well construction and completio …
  • Hero AG:企業の戦略・SWOT・財務分析
    Hero AG - Strategy, SWOT and Corporate Finance Report Summary Hero AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • ValiRx Plc (VAL):企業の財務・戦略的SWOT分析
    Summary ValiRx Plc (ValiRx) is a life science company that develops therapeutics for the treatment of clinical stage cancer. The company’s products include VAL201-prostate cancer, VAL401-lung cancer, GeneICE – BCL-2, and NAV3 cancer screening test. It uses GeneICE technology, which enables silencing …
  • Anthera Pharmaceuticals Inc:企業のM&A・事業提携・投資動向
    Anthera Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Anthera Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Duke Energy Corp:企業の発電所・SWOT分析2018
    Duke Energy Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Royal DSM NV (DSM)-医療機器分野:企業M&A・提携分析
    Summary Royal DSM NV (DSM) is a life sciences and materials sciences company, which focuses on health, nutrition and materials sectors. The company offers a wide range of products such as anti-invectives, polyesters, vitamins and other ingredients, performance materials to diverse end markets. It pr …
  • Tokio Marine Asia Pte. Ltd.
    Tokio Marine Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tokio Marine Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Quadra – Power Generation:発電所・企業SWOT分析
    Quadra - Power Generation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Cellnet Group Ltd (CLT):企業の財務・戦略的SWOT分析
    Cellnet Group Ltd (CLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Creganna Medical:医療機器:M&Aディール及び事業提携情報
    Summary Creganna Medical (Creganna), a subsidiary of TE Connectivity Ltd, formerly known as Creganna-Tactx Medical, is a provider of medical device outsourcing solutions. The company is. It undertakes the design, manufacturing and commercialization of minimally & less invasive delivery and access de …
  • Chesapeake Energy Corporation (CHK):石油・ガス:M&Aディール及び事業提携情報
    Summary Chesapeake Energy Corp (Chesapeake) is an upstream oil and gas company in the US. The company explores for, develops and produces oil and gas from its assets. It has liquid operations in Eagle Ford Shale; the Utica Shale; the Granite Wash, Cleveland, Tonkawa and Mississippian Lime plays in t …
  • Daily Mail and General Trust plc:企業の戦略・SWOT・財務分析
    Daily Mail and General Trust plc - Strategy, SWOT and Corporate Finance Report Summary Daily Mail and General Trust plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • SoCore Energy LLC:電力:M&Aディール及び事業提携情報
    Summary SoCore Energy LLC (SoCore Energy), a subsidiary of Edison International is a provider of solar solutions. The company’s services include solar energy development and installations, production monitoring, cost saving energy solutions, financing, procurement, technical and project management, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆